Levetiracetam

CAS 102767-28-2 38 API suppliersSmall Molecule

Overview

Levetiracetam is an anticonvulsant medication used to treat epilepsy. It is known to inhibit burst firing without affecting normal neuronal excitability, thereby preventing the propagation of seizure activity.

API suppliers (38)

Suppliers of Levetiracetam evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
India21China7Israel1United States1

Country recorded for 30 of 38 suppliers.

19 of 38 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 38 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (152 approved US products), the latest listed US patent on Levetiracetam expires 14 Mar 2034. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
2-(2-oxopyrrolidin-1-yl)butanamide
Canonical SMILES
CCC(C(=O)N)N1CCCC1=O
InChIKey
HPHUVLMMVZITSG-UHFFFAOYSA-N

Therapeutic areas

NeurologyEpilepsyAnticonvulsants
Verified Supplier Partner

Do you supply Levetiracetam? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.